Delcath Systems (DCTH) Stock: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$16.12
-0.05 (-0.31%)
▼
5d:
+0.88%
30d:
-5.45%
90d:
+39.69%
BUY
MODERATE Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DCTH shows positive signals but monitor for confirmation. Market pricing in 39.0% growth. Moderate conviction.
💡 BUY OPPORTUNITY: DCTH shows positive signals but monitor for confirmation. Market pricing in 39.0% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $16.12, which is considered oversold relative to its 30-day fair value range of $16.17 to $17.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 359.3) compared to its historical average (133.7). At these levels, the market is pricing in 39.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, DCTH is in a strong uptrend. The price is currently testing key support at $15.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DCTH scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $24.00 (+48.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DCTH is in a strong uptrend. The price is currently testing key support at $15.68. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DCTH scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $24.00 (+48.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.17 -
$17.00
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
88.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.4% below Wall St target ($24.00)
- BEARISH: Market expects 39.0% growth - appears too optimistic based on history
- BULLISH: Bottoming setup score 68/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$16.17 -
$17.00
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.52
(9.4%)
Support & Resistance Levels
Support Level
$15.68
Resistance Level
$16.78
Current Trend
Strong Uptrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
359.33
Wall Street Target
$24.00
(+48.4%)
Revenue Growth (YoY)
20.6%
Profit Margin
0.6%
Valuation Premium vs History
+39.0% premium
PE vs Historical
359.3 vs 133.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+39.0%
(market-implied from PE analysis)
1-Year Target
$22.48
(+39%)
2-Year Target
$31.24
(+93%)
3-Year Target
$43.43
(+169%)
3-Yr Target (if PE normalizes)
(PE: 359→134)
PE COMPRESSION
$16.16
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: September 16, 2026 3:08 PM ET
Data refreshes hourly during market hours. Next update: 4:08 PM
Data refreshes hourly during market hours. Next update: 4:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$62 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 51 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 47 HOLD |
